Cited by 1,033Cancer Immunotherapy and BiomarkersT-cell and B-cell ImmunologyImmunotherapy and Immune Responses

The DOI matches its Crossref record; 44 of the 45 references it cites were found in a registry or an index.

Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor Microenvironment

Open access

Ma, Xingzhe, Bi, Enguang, Lu, Yong, Su, Pan, Huang, Chunjian, Liu, Lintao, Wang, Qiang, Yang, Maojie, Kalady, Matthew F., Qian, Jianfei, Zhang, Aijun, Gupte, Anisha A., Hamilton, Dale J., Zheng, Chengyun, Yi, Qing·2019·Cell Metabolism

DOI 10.1016/j.cmet.2019.04.002PMC PMC7061417

Open this paper in CoChat — free account Open PDF

Abstract

Tumor-infiltrating T cells often lose their effector function; however, the mechanisms are incompletely understood. We report that cholesterol in the tumor microenvironment induces CD8+ T cell expression of immune checkpoints and exhaustion. Tumor tissues enriched with cholesterol and cholesterol content in tumor-infiltrating CD8+ T cells were positively and progressively associated with upregulated T cell expression of PD-1, 2B4, TIM-3, and LAG-3. Adoptively transferred CD8+ T cells acquired cholesterol, expressed high levels of immune checkpoints, and became exhausted upon entering a tumor. Tumor culture supernatant or cholesterol induced immune checkpoint expression by increasing endoplasmic reticulum (ER) stress in CD8+ T cells. Consequently, the ER stress sensor XBP1 was activated and regulated PD-1 and 2B4 transcription. Inhibiting XBP1 or reducing cholesterol in CD8+ T cells effectively restored antitumor activity. This study reveals a mechanism underlying T cell exhaustion and suggests a new strategy for restoring T cell function by reducing cholesterol to enhance T cell-based immunotherapy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.cmet.2019.04.002

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cancer immunotherapy using checkpoint blockade
Ribas, A., & Wolchok, J. D. (2018) · Science · doi:10.1126/science.aar4060 · Cited by 6,791
T cell exhaustion
Wherry, E. J. (2011) · Nature Immunology · doi:10.1038/ni.2035 · Cited by 4,062 · cited 13×
“Tumor-infiltrating CD8+ T cells are associated with progressive loss of effector function due to prolonged antigen exposure and a suppressive tumor microenvironment (Wherry, 2011).”
Influential
CTLA-4 and PD-1 Pathways: Similarities, Differences, and Implications of Their Inhibition
Buchbinder, E. I., & Desai, A. (2016) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000000239 · Cited by 2,360 · cited 1×
“, the combination of anti-PD-1 with anti-CTLA-4 (Buchbinder and Desai, 2016; Duraiswamy et al., 2013; Dyck and Mills, 2017), anti-PD-1 with anti-TIM-3 (Sakuishi et al.”
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
Sakuishi, K., Apetoh, L., Sullivan, J. M., Blazar, B. R., Kuchroo, V. K., & Anderson, A. C. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100643 · Cited by 2,072
Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
Woo, S.-R., Turnis, M. E., Goldberg, M. V., Bankoti, J., Selby, M., Nirschl, C. J., Bettini, M. L., Gravano, D. M., Vogel, P., Liu, C. L., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1620 · Cited by 1,647
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
Boussiotis, V. A. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1514296 · Cited by 1,367
Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments
Angelin, A., Gil‐de‐Gómez, L., Dahiya, S., Jiao, J., Guo, L., Levine, M. H., Wang, Z., Quinn, W. J., Kopinski, P. K., Wang, L., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.12.018 · Cited by 1,263
VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors
Voron, T., Colussi, O., Marcheteau, E., Pernot, S., Nizard, M., Pointet, A.-L., Latreche, S., Bergaya, S., Benhamouda, N., Tanchot, C., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20140559 · Cited by 1,179
Statin use and reduced cancer-related mortality
Nielsen, S. F., Nordestgaard, B. G., & Bojesen, S. E. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1201735 · Cited by 1,030
Potentiating the antitumour response of CD8+ T cells by modulating cholesterol metabolism
Yang, W., Bai, Y., Xiong, Y., Zhang, J., Chen, S., Zheng, X., Meng, X., Li, L., Wang, J., Xu, C., et al. (2016) · Nature · doi:10.1038/nature17412 · Cited by 1,010

Flagged first, then by citations

Show all 45 references

1 of the 45 references couldn’t be matched to a known paper.

Sorted by citations

Items 201–300 of 1,000

Targeting metabolic dysfunction of CD8 T cells and natural killer cells in cancer
Viel, S., Vivier, É., Walzer, T., & Marçais, A. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01098-w · Cited by 53
Ferroptosis: CD8+T cells’ blade to destroy tumor cells or poison for self-destruction
Liang, Y., Zhao, Y., Li, X., Li, X., & Zhao, Y. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02415-x · Cited by 56
T cell metabolism in homeostasis and cancer immunity
Wei, J., Zheng, W., Chapman, N. M., Geiger, T. L., & Chi, H. (2021) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2021.02.003 · Cited by 52
Cholesterol Metabolism in Cancer and Cell Death
Chen, F., Lu, Y., Lin, J., Kang, R., & Liu, J. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0340 · Cited by 53
Self-citation
Statins as anti‐tumor agents: A paradigm for repurposed drugs
Tripathi, S., Gupta, E., & Galande, S. (2024) · Cancer Reports · doi:10.1002/cnr2.2078 · Cited by 52
A CD36-dependent non-canonical lipid metabolism program promotes immune escape and resistance to hypomethylating agent therapy in AML
Guo, H., Feng, R.-X., Zhang, Y., Yu, Y., Lu, W., Liu, J.-J., Yang, S., Zhao, C., Zhang, Z.-L., Yu, S., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101592 · Cited by 50
Cholesterol Metabolism as a Potential Therapeutic Target and a Prognostic Biomarker for Cancer Immunotherapy
Zhang, H., Zhao, W., Li, X., & He, Y. (2021) · OncoTargets and Therapy · doi:10.2147/ott.s315998 · Cited by 49
Metabolic Reprogramming in the Tumor Microenvironment With Immunocytes and Immune Checkpoints
Xu, Y., He, L., Fu, Q., & Hu, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.759015 · Cited by 51
Mechanisms of drug resistance to immune checkpoint inhibitors in non-small cell lung cancer
Zhou, K., Li, S., Zhao, Y., & Cheng, K. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1127071 · Cited by 49
TGF-β1 induces PD-1 expression in macrophages through SMAD3/STAT3 cooperative signaling in chronic inflammation
Lei, Z., Tang, R., Yu, W., Mao, C., Xue, W., Shen, J., Yu, J., Wang, X., Qi, X., Wei, C., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.165544 · Cited by 51
Cholesterol efflux from C1QB-expressing macrophages is associated with resistance to chimeric antigen receptor T cell therapy in primary refractory diffuse large B cell lymphoma
Yan, Z., Dong, Y., Qiao, N., Zhang, Y., Wu, W., Zhu, Y., Wang, L., Cheng, S., Xu, P.-P., Zhou, Z., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49495-4 · Cited by 48
The UPRising connection between endoplasmic reticulum stress and the tumor microenvironment
Urra, H., Aravena, R., González-Johnson, L., & Hetz, C. A. (2024) · Trends in cancer · doi:10.1016/j.trecan.2024.09.011 · Cited by 49
Harnessing ferroptosis to transform glioblastoma therapy and surmount treatment resistance
Singh, S., Mohapatra, I., Barik, D., Zheng, H., Kim, S., Sharma, M., Chen, C. C., & Singh, G. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02744-x · Cited by 48
Low profile high value target: The role of OxLDL in cancer
Bitorina, A. V., Oligschlaeger, Y., Shiri‐Sverdlov, R., & Theys, J. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2019.158518 · Cited by 51
Immunometabolism in the Tumor Microenvironment
Roy, D. G., Kaymak, I., Williams, K. S., Ma, E. H., & Jones, R. G. (2020) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030518-055817 · Cited by 49
Overview: Lipid Metabolism in the Tumor Microenvironment
Ma, K., & Zhang, L. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-33-6785-2_3 · Cited by 47
Reduction and exhausted features of T lymphocytes under serological changes, and prognostic factors in COVID-19 progression
Mahmoodpoor, A., Hosseini, M. S., Soltani‐Zangbar, M. S., Sanaie, S., Maleki, L. A., Saghaleini, S. H., Ostadi, Z., Hajivalili, M., Bayatmakoo, Z., Haji-Fatahaliha, M., et al. (2021) · Molecular Immunology · doi:10.1016/j.molimm.2021.06.001 · Cited by 47
Targeting Metabolism to Control Immune Responses in Cancer and Improve Checkpoint Blockade Immunotherapy
Luby, A., & Alves‐Guerra, M. (2021) · Cancers · doi:10.3390/cancers13235912 · Cited by 49
Revealing the crosstalk between nasopharyngeal carcinoma and immune cells in the tumor microenvironment
Jiang, J., & Ying, H. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02457-4 · Cited by 47
The Impacts of Cholesterol, Oxysterols, and Cholesterol Lowering Dietary Compounds on the Immune System
Yanagisawa, R., He, C., Asai, A., Hellwig, M., Henle, T., & Toda, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012236 · Cited by 48
Cell metabolism-based optimization strategy of CAR-T cell function in cancer therapy
Li, W., Pan, X., Chen, L., Cui, H., Mo, S., Pan, Y., Shen, Y., Shi, M., Wu, J., Luo, F., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1186383 · Cited by 49
ATP6V0A1-dependent cholesterol absorption in colorectal cancer cells triggers immunosuppressive signaling to inactivate memory CD8+ T cells
Huang, T.-X., Huang, H.-S., Dong, S., Chen, J., Zhang, B., Li, H., Zhang, T., Xie, Q., Long, Q., Yang, Y., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50077-7 · Cited by 48
Diverse Immunoregulatory Roles of Oxysterols—The Oxidized Cholesterol Metabolites
Choi, C., & Finlay, D. K. (2020) · Metabolites · doi:10.3390/metabo10100384 · Cited by 48
Increased serum cholesterol and long-chain fatty acid levels are associated with the efficacy of nivolumab in patients with non-small cell lung cancer
Karayama, M., Inui, N., Inoue, Y., Yoshimura, K., Mori, K., Hozumi, H., Suzuki, Y., Furuhashi, K., Fujisawa, T., Enomoto, N., et al. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-021-02979-4 · Cited by 47
Research progress in the role and mechanism of LPCAT3 in metabolic related diseases and cancer
Shao, G., Qian, Y., Lu, L., Liu, Y., Wu, T., Ji, G., & Xu, H. (2022) · Journal of Cancer · doi:10.7150/jca.71619 · Cited by 46
CD36 and Its Role in Regulating the Tumor Microenvironment
Liao, X., Yan, S., Li, J., Jiang, C., Huang, S., Liu, S., Zou, X., Zhang, G., Zou, J., & Liu, Q. (2022) · Current Oncology · doi:10.3390/curroncol29110642 · Cited by 47
A novel T-cell exhaustion-related feature can accurately predict the prognosis of OC patients
Yuan, K., Zhao, S., Ye, B., Wang, Q., Liu, Y., Zhang, P., Xie, J., Chi, H., Chen, Y., Cheng, C., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1192777 · Cited by 47
Self-citation
Tumor endothelial cell‐induced CD8+ T‐cell exhaustion via GPNMB in hepatocellular carcinoma
Sakano, Y., Noda, T., Kobayashi, S., Sasaki, K., Iwagami, Y., Yamada, D., Tomimaru, Y., Akita, H., Gotoh, K., Takahashi, H., et al. (2022) · Cancer Science · doi:10.1111/cas.15331 · Cited by 46
Lipid peroxidation of immune cells in cancer
Xiao, L., Xian, M., Zhang, C., Guo, Q., & Yi, Q. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1322746 · Cited by 47
Self-citation
T cell exhaustion in human cancers
Kang, K., Lin, X., Chen, P., Liu, H., Liu, F., Xiong, W., Li, G., Yi, M., Li, X., Wang, H., et al. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189162 · Cited by 49
Effects of T2DM on cancer progression: pivotal precipitating factors and underlying mechanisms
Zhang, Y., Li, Y., Xue, C., Li, S., Gao, Z., & Qin, K. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1396022 · Cited by 45
Immunometabolism and oxidative stress: roles and therapeutic strategies in cancer and aging
Zhou, N.-J., Bao, W.-Q., Zhang, C., Jiang, M., Liang, T.-L., Ma, G.-Y., Liu, L., Pan, H., & Li, R.-Z. (2025) · npj Aging · doi:10.1038/s41514-025-00250-z · Cited by 45
Self-citation
Tumor microenvironment metabolites directing T cell differentiation and function
Liu, X., Hoft, D. F., & Peng, G. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.12.004 · Cited by 45
Diet, nutrient supply, and tumor immune responses
McIntyre, C., Temesgen, A., & Lynch, L. (2023) · Trends in cancer · doi:10.1016/j.trecan.2023.06.003 · Cited by 43
Metabolic rewiring and communication in cancer immunity
Chapman, N. M., & Chi, H. (2024) · Cell chemical biology · doi:10.1016/j.chembiol.2024.02.001 · Cited by 44
The evolving landscape of PCSK9 inhibition in cancer
Oza, P. P., & Kashfi, K. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175721 · Cited by 43
Exhausted T cells hijacking the cancer-immunity cycle: Assets and liabilities
Brunell, A. E., Lahesmaa, R., Autio, A. K., & Thotakura, A. K. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1151632 · Cited by 46
Targeting the Tumor Microenvironment: A Literature Review of the Novel Anti-Tumor Mechanism of Statins
Zhu, P., Wang, M., Chen, Z.-L., & Yang, L. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.761107 · Cited by 45
Fatty Acid Metabolism in Myeloid-Derived Suppressor Cells and Tumor-Associated Macrophages: Key Factor in Cancer Immune Evasion
Siddiqui, S., & Glauben, R. (2022) · Cancers · doi:10.3390/cancers14010250 · Cited by 41
Nanozyme‐encoded luminescent detection for food safety analysis: An overview of mechanisms and recent applications
Li, Y., Sun, J., Huang, L., Liu, S., Wang, S., Zhang, D., Zhu, M.-Q., & Wang, J. (2022) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.13055 · Cited by 41
Landscapes and mechanisms of CD8+ T cell exhaustion in gastrointestinal cancer
Ding, J., Yang, K., Zhou, H., Huang, Y.-F., Li, H., & Zong, Z. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1149622 · Cited by 45
Metabolites and Immune Response in Tumor Microenvironments
Cortellino, S., & Longo, V. D. (2023) · Cancers · doi:10.3390/cancers15153898 · Cited by 43
Metabolic advantages of regulatory T cells dictated by cancer cells
Kondo, M., Kumagai, S., & Nishikawa, H. (2023) · International Immunology · doi:10.1093/intimm/dxad035 · Cited by 42
The immunosuppressive landscape in tumor microenvironment
Liu, W., Zhou, H., Lai, W., Hu, C., Xu, R., Gu, P., Luo, M., Zhang, R., & Li, G. (2024) · Immunologic Research · doi:10.1007/s12026-024-09483-8 · Cited by 44
The Pivotal Role of the Dysregulation of Cholesterol Homeostasis in Cancer: Implications for Therapeutic Targets
Mok, E. H. K., & Lee, T. K. (2020) · Cancers · doi:10.3390/cancers12061410 · Cited by 43
Blocking Cholesterol Metabolism with Tumor‐Penetrable Nanovesicles to Improve Photodynamic Cancer Immunotherapy
Liu, X., Zhao, Z., Sun, X., Wang, J., Yi, W., Wang, D., & Li, Y. (2022) · Small Methods · doi:10.1002/smtd.202200898 · Cited by 41
Cholesterol induction in CD8+ T cell exhaustion in colorectal cancer via the regulation of endoplasmic reticulum-mitochondria contact sites
Han, S., Wu, Y., Jing, Z., Qiang, Y., Jiang, Y., Quan, Q., Yin, J., Jiang, L., & Yang, X. (2023) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-023-03555-8 · Cited by 40
Targeting T-cell metabolism to boost immune checkpoint inhibitor therapy
Li, H., Zhao, A., Li, M., Shi, L., Han, Q., & Hou, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1046755 · Cited by 42
The Interplay between T Cells and Cancer: The Basis of Immunotherapy
Chen, C., Liu, X., Chang, C., Wang, H. Y., & Wang, R. (2023) · Genes · doi:10.3390/genes14051008 · Cited by 42
Mechanoregulatory Cholesterol Oxidase‐Functionalized Nanoscale Metal–Organic Framework Stimulates Pyroptosis and Reinvigorates T Cells
Zhen, W., Luo, T., Wang, Z., Jiang, X., Yuan, E., Weichselbaum, R. R., & Lin, W. (2023) · Small · doi:10.1002/smll.202305440 · Cited by 39
Cholesterol effects on the tumor immune microenvironment: from fundamental concepts to mechanisms and implications
Lagunas‐Rangel, F. A. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1579054 · Cited by 39
Advances in T Cells Based on Inflammation in Metabolic Diseases
Yu, W., Li, C., Zhang, D., Li, Z., Xia, P., Liu, X., Cai, X., Yang, P., Ling, J., Zhang, J., et al. (2022) · Cells · doi:10.3390/cells11223554 · Cited by 41
Metabolic dynamics instruct CD8 + T‐cell differentiation and functions
Bevilacqua, A., Li, Z., & Ho, P. (2022) · European Journal of Immunology · doi:10.1002/eji.202149486 · Cited by 41
Progression of m6A in the tumor microenvironment: hypoxia, immune and metabolic reprogramming
Han, X., Zhu, Y., Ke, J., Zhai, Y., Huang, M., Zhang, X., He, H., Zhang, X., Zhao, X., Guo, K., et al. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02092-2 · Cited by 40
TMED4 facilitates regulatory T cell suppressive function via ROS homeostasis in tumor and autoimmune mouse models
Jiang, Z., Wang, H., Wang, X., Duo, H., Tao, Y., Jia, L., Li, X., Liu, J., Ni, J., Wu, E. J., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci179874 · Cited by 38
Metabolic Reprogramming of Glycolysis, Lipids, and Amino Acids in Tumors: Impact on CD8 + T Cell Function and Targeted Therapeutic Strategies
Liang, P., Li, Z., Chen, Z., Chen, Z., Jin, T., He, F., Chen, X., Gou, H., & Yang, K. (2025) · The FASEB Journal · doi:10.1096/fj.202403019r · Cited by 42
Amino acids and RagD potentiate mTORC1 activation in CD8 + T cells to confer antitumor immunity
Zhang, Y., Hu, H., Liu, W., Yan, S., Li, Y., Tan, L., Chen, Y., Liu, J., Peng, Z., Yuan, Y., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-002137 · Cited by 37
Dysregulation of cellular membrane homeostasis as a crucial modulator of cancer risk
Erazo‐Oliveras, A., Muñoz‐Vega, M., Salinas, M. L., Wang, X., & Chapkin, R. S. (2022) · FEBS Journal · doi:10.1111/febs.16665 · Cited by 38
tRNA m1A modification regulates cholesterol biosynthesis to promote antitumor immunity of CD8+ T cells
Miao, S., Li, H., Song, X., Liu, Y., Wang, G., Kan, C., Ye, Y., Liu, R., & Li, H. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20240559 · Cited by 37
Aberrant Cholesterol Metabolism in Ovarian Cancer: Identification of Novel Therapeutic Targets
He, J., Siu, M. K. Y., Ngan, H., & Chan, K. K. L. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.738177 · Cited by 38
Targeting lipid metabolism reprogramming of immunocytes in response to the tumor microenvironment stressor: A potential approach for tumor therapy
Zhang, M., Wei, T., Zhang, X., & Guo, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.937406 · Cited by 37
Effect of metabolic reprogramming on the immune microenvironment in gastric cancer
Shang, Z., Ma, Z., Wu, E., Chen, X., Tuo, B., Li, T., & Liu, X. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.116030 · Cited by 36
CSN6‐SPOP‐HMGCS1 Axis Promotes Hepatocellular Carcinoma Progression via YAP1 Activation
Li, K., Zhang, J., Lyu, H., Yang, J., Wei, W., Wang, Y., Luo, H., Zhang, Y., Jiang, X. J., Yi, H., et al. (2024) · Advanced Science · doi:10.1002/advs.202306827 · Cited by 36
Precise targeting of lipid metabolism in the era of immuno-oncology and the latest advances in nano-based drug delivery systems for cancer therapy
Zhang, H., Li, Y., Huang, J., Shen, L., & Yang, X. W. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.07.021 · Cited by 38
Intratumoral mycobiome heterogeneity influences the tumor microenvironment and immunotherapy outcomes in renal cell carcinoma
Mou, W., Deng, Z., Zhu, L., Jiang, A., Lin, A., Xu, L., Deng, G., Huang, H., Guo, Z., Zhu, B., et al. (2025) · Science Advances · doi:10.1126/sciadv.adu1727 · Cited by 36
Lipid-mediated regulation of the cancer-immune crosstalk
Ma, Y., Zhang, S., Jin, Z., & Shi, M. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105131 · Cited by 36
Targeting dysregulated lipid metabolism in the tumor microenvironment
Kim, D., Song, N., & Yim, H. (2023) · Archives of Pharmacal Research · doi:10.1007/s12272-023-01473-y · Cited by 38
A propensity score-matched analysis of the impact of statin therapy on the outcomes of patients with non-small-cell lung cancer receiving anti-PD-1 monotherapy: a multicenter retrospective study
Takada, K., Shimokawa, M., Takamori, S., Shimamatsu, S., Hirai, F., Tagawa, T., Okamoto, T., Hamatake, M., Tsuchiya‐Kawano, Y., Otsubo, K., et al. (2022) · BMC Cancer · doi:10.1186/s12885-022-09385-8 · Cited by 34
Lipid Metabolism in Breast Cancer: From Basic Research to Clinical Application
Huang, X., Liu, B., & Shen, S. (2025) · Cancers · doi:10.3390/cancers17040650 · Cited by 34
Regulation of T cell exhaustion and stemness: molecular mechanisms and implications for cancer immunotherapy
Chen, Z., Zhu, Z., Hu, T., Yao, C., & Wu, T. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01378-4 · Cited by 37
Oxidized Lipoproteins Promote Resistance to Cancer Immunotherapy Independent of Patient Obesity
Khojandi, N., Kuehm, L. M., Piening, A., Donlin, M. J., Hsueh, E. C., Schwartz, T. L., Farrell, K., Richart, J. M., Geerling, E., Pinto, A. K., et al. (2020) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0358 · Cited by 36
Endoplasmic reticulum stress in melanoma pathogenesis and resistance
Kong, Y., Jiang, J. L., Huang, Y., Li, L., Liu, X., Jin, Z., Wei, F., Liu, X., Zhang, S., Duan, X., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113741 · Cited by 35
Immunometabolism in the tumor microenvironment and its related research progress
Zhang, Z., Hu, Y., Chen, Y., Chen, Z., Zhu, Y., Chen, M., Xia, J., Sun, Y., & Xu, W. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1024789 · Cited by 35
Endoplasmic Reticulum Stress in Cancer
Zhou, R., Wang, W., Li, B., Zhu, L., Huang, J., & Li, X. (2025) · MedComm · doi:10.1002/mco2.70263 · Cited by 39
Metabolic crosstalk among cancer-associated fibroblasts, adipocytes and immune cells as an immunosuppressive tumor microenvironment driver
Kim, T. H., Lim, S. H., Lee, H., Chae, Y. C., & Min, D. S. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01650-1 · Cited by 34
PD-1 does not mark tumor-infiltrating CD8+ T cell dysfunction in human gastric cancer
Shen, Y., Teng, Y., Lv, Y.-P., Zhao, Y., Qiu, Y., Chen, W., Wang, L., Wang, Y., Mao, F., Cheng, P., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000422 · Cited by 33
Cholesterol-Lowering Intervention Decreases mTOR Complex 2 Signaling and Enhances Antitumor Immunity
Wang, Y., You, S., Su, S., Yeon, A., Lo, E. M., Kim, S., Mohler, J. L., Freeman, M. R., & Kim, H. L. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-1535 · Cited by 36
SCD1 inhibition enhances the effector functions of CD8 + T cells via ACAT1 ‐dependent reduction of esterified cholesterol
Sugi, T., Katoh, Y., Ikeda, T., Seta, D., Iwata, T., Nishio, H., Sugawara, M., Kato, D., Katoh, K., Kawana, K., et al. (2023) · Cancer Science · doi:10.1111/cas.15999 · Cited by 32
Targeting metabolic pathways to counter cancer immunotherapy resistance
Agarwala, Y., Brauns, T. A., Sluder, A. E., Poznansky, M. C., & Gemechu, Y. (2024) · Trends in Immunology · doi:10.1016/j.it.2024.05.006 · Cited by 33
Ferroptosis in immune cells: Implications for tumor immunity and cancer therapy
Gao, J., Zhang, X., Liu, Y., & Gu, X. (2025) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2025.06.007 · Cited by 34
Cholesterol-modifying drugs in COVID-19
Schmidt, N. M., Wing, P. A. C., McKeating, J. A., & Maini, M. K. (2020) · Oxford Open Immunology · doi:10.1093/oxfimm/iqaa001 · Cited by 32
Ovarian Cancer Risk in Relation to Blood Cholesterol and Triglycerides
Trabert, B. L., Hathaway, C. A., Rice, M. S., Rimm, E. B., Sluss, P. M., Terry, K. L., Zeleznik, O. A., & Tworoger, S. S. (2021) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-21-0443 · Cited by 32
High-affinity SOAT1 ligands remodeled cholesterol metabolism program to inhibit tumor growth
Wang, Z., Wang, M., Zhang, M., Xu, K., Zhang, X., Xie, Y., Zhang, Y., Chang, C., Li, X., Sun, A., et al. (2022) · BMC Medicine · doi:10.1186/s12916-022-02436-8 · Cited by 32
Targeting ACAT1 in cancer: from threat to treatment
Sun, T., & Xiao, X. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1395192 · Cited by 31
Single cell analyses reveal the PD-1 blockade response-related immune features in hepatocellular carcinoma
Li, Y., Li, F., Xu, L., Shi, X., Xue, H., Liu, J., Bai, S., Wu, Y., Zhao, Y., Xue, F., et al. (2024) · Theranostics · doi:10.7150/thno.95971 · Cited by 32
Peroxisomes and PPARs: Emerging role as master regulators of cancer metabolism
Pratama, A. M., Sharma, M., Naidu, S., Bömmel, H. M., Prabhuswamimath, S. C., Madhusudhan, T., Wihadmadyatami, H., Bachhuka, A., & Karnati, S. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.102044 · Cited by 31
The metabolism-immune axis in colorectal cancer: remodeling the tumor microenvironment through metabolite signaling
Hu, S., Heng, H., Yang, F., Wang, M., Liu, G., Xiang, Y., & Miao, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1735873 · Cited by 32
Metabolic and Mitochondrial Functioning in Chimeric Antigen Receptor (CAR)—T Cells
Rad, S. M. A. H., Halpin, J. C., Mollaei, M., Smith‐Bell, S. W., Hirankarn, N., & McLellan, A. D. (2021) · Cancers · doi:10.3390/cancers13061229 · Cited by 31
Immunologic Aspects of Dyslipidemia: a Critical Regulator of Adaptive Immunity and Immune Disorders
Kim, D., Chung, H., Lee, J.-E., Kim, J., Hwang, J., & Chung, Y. (2021) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2021.10.2.184 · Cited by 33
Exploiting the obesity-associated immune microenvironment for cancer therapeutics
Desharnais, L., Walsh, L. A., & Quail, D. F. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107923 · Cited by 31
Cholesterol accumulation on dendritic cells reverses chronic hepatitis B virus infection-induced dysfunction
Zhao, H., Yu, Y., Wang, Y., Zhao, L., Yang, A., Hu, Y., Pan, Z., Wang, Z., Yang, J., Han, Q., et al. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-022-00939-1 · Cited by 31
Targeting PCSK9 reduces cancer cell stemness and enhances antitumor immunity in head and neck cancer
Yang, Q., Wang, S., Liu, Y., Song, A., Wu, Z., Wan, S., Li, H., & Sun, Z. (2023) · iScience · doi:10.1016/j.isci.2023.106916 · Cited by 31
Unravelling the role of immune cells and FN1 in the recurrence and therapeutic process of skull base chordoma
Huo, X., Ma, S., Wang, C., Song, L., Yao, B.-H., Zhu, S., Li, P., Wang, L., Wu, Z., & Wang, K. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1429 · Cited by 31
Single-cell atlas of diverse immune populations in the advanced biliary tract cancer microenvironment
Shi, X., Li, Z., Yao, R.-Q., Cheng, Q., Li, W., Wu, R. T., Xie, Z., Zhu, Y., Qiu, X., Yang, S., et al. (2022) · npj Precision Oncology · doi:10.1038/s41698-022-00300-9 · Cited by 31
A single-cell characterised signature integrating heterogeneity and microenvironment of lung adenocarcinoma for prognostic stratification
Xu, J., Zhang, Y., Li, M., Shao, Z., Dong, Y., Li, Q., Bai, H., Duan, J., Zhong, J., Wan, R., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105092 · Cited by 34
Metabolic Signaling in the Tumor Microenvironment
Clay, R., Li, K., & Jin, L. (2025) · Cancers · doi:10.3390/cancers17010155 · Cited by 31
Prognostic value of lipid metabolism‐related genes in head and neck squamous cell carcinoma
Xiong, Y., Si, Y., Feng, Y., Zhuo, S., Cui, B., & Zhang, Z. (2020) · Immunity Inflammation and Disease · doi:10.1002/iid3.379 · Cited by 30
Metabolites in the Tumor Microenvironment Reprogram Functions of Immune Effector Cells Through Epigenetic Modifications
Li, Y., Wu, Y., & Hu, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.641883 · Cited by 31
The role of tumor metabolism in modulating T-Cell activity and in optimizing immunotherapy
Ganjoo, S., Gupta, P., Corbali, H. I., Nanez, S., Riad, T. S., Duong, L. K., Barsoumian, H. B., Masrorpour, F., Jiang, H., Welsh, J. W., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1172931 · Cited by 32
A Cu‐Based Single‐Atom Nanozyme Platform with Multi‐Enzyme Simulated Activities for Immunotherapy of Prostate Cancer by Regulating Cholesterol Metabolism and Triggering Pyroptosis
Xu, B., Niu, R., Deng, R., Tang, Y., Wang, C., & Wang, Y. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202405265 · Cited by 29

Authors: Ma, X., Bi, E., Lu, Y., Su, P., Huang, C., Liu, L., Wang, Q., Yang, M., Kalady, M. F., Qian, J., Zhang, A., Gupte, A. A., Hamilton, D. J., Zheng, C., & Yi, Q.
Affiliations: Houston Methodist (US)
Wake Forest University Health Sciences (US)
Cleveland Clinic (US)
Houston Methodist Research Institute (US)
Second Hospital of Shandong University (CN)
Corresponding author: Yi, Qing
ORCID: Ma, Xingzhe
Bi, Enguang
Lu, Yong
Liu, Lintao
Wang, Qiang
Kalady, Matthew F.
Qian, Jianfei
Zhang, Aijun
Gupte, Anisha A.
Hamilton, Dale J.
Zheng, Chengyun
Yi, Qing
Venue: Cell Metabolism
Publisher: Elsevier BV
Published: 2019-07
Volume: 30
Issue: 1
Pages: 143-156.e5
ISSN: 1550-4131 (ISSN-L)
DOI: 10.1016/j.cmet.2019.04.002
PMC: PMC7061417
OpenAlex: W2941036215
Cited by: 1,033
References: 45
Citations by year: 2026: 176 · 2025: 204 · 2024: 187 · 2023: 169 · 2022: 136 · 2021: 100 · 2020: 47 · 2019: 12
FWCI: 31.24
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 367 d)
Locations: Cell Metabolism (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health
Topics: Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords: cholesterol, CD8+ T cell exhaustion, tumor microenvironment, immune checkpoint, PD-1, 2B4, TIM-3, LAG-3, endoplasmic reticulum stress, XBP1, adoptive T cell therapy, antitumor immunity, cholesterol metabolism
MeSH terms: Animals, Cholesterol, Flow Cytometry, Humans, Immunotherapy, Melanoma, Experimental, Blotting, Western, CD8-Positive T-Lymphocytes, Immunoprecipitation, Mice, Tumor Microenvironment, Real-Time Polymerase Chain Reaction, Programmed Cell Death 1 Receptor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor Microenvironment

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks